Multiple Myeloma Hub | Quarter Four 2019 Update

The Multiple Myeloma (MM) Hub continues to provide the latest clinical updates to the myeloma community.

Guided by a Steering Committee formed of world-leading experts in MM and run in collaboration with the European School of Haematology (ESH), the MM Hub continues to expand its online presence, bringing the most current clinical data to the global myeloma community. With the aim of impacting real-world clinical practice, the MM Hub disseminates data from international congresses via social media platforms and through the MM Hub website and provides video interviews with experts in the field, enabling treatment teams to make informed therapeutic decisions.

Last quarter, the MM Hub focused on educational themes such as measurable residual disease and transplantation. Based on each theme, the MM Hub generate targeted content with the intention of lifting levels of knowledge in areas of unmet educational need. In October 2019, the MM Hub attended the Myeloma and Plasma Cell Disorders Meeting, London, UK, providing live session coverage and a summary of the plenary talk. Additionally, the MM Hub attended the 61st American Society of Hematology (ASH) Annual Meeting & Exposition, Florida, US, publishing 30 video interviews with world-leading experts and numerous articles alongside live session coverage.

The MM hub is an unbiased source of information for healthcare professionals for all-things related to myeloma; from the latest literature, to drug approvals, trial updates, expert opinions and data from international congresses. Delivered by Scientific Education Support (SES), the MM Hub are delighted to be a part of the myeloma community and enhancing the levels of collective knowledge.

It is only possible to remain at the forefront of the myeloma field thanks to our sponsors. The MM Hub would like to acknowledge Janssen Oncology (Silver), Amgen (Bronze), GSK (Contributor) and Karyopharm (Contributor) for their support of the initiative.

For more information on the MM Hub, please visit: For media enquiries, or to explore collaboration opportunities, please contact:

Press release distributed by Pressat on behalf of Scientific Education Support, on Friday 17 January, 2020. For more information subscribe and follow

MM Multiple Myeloma Cancer Hematology Medical & Pharmaceutical
Published By

Scientific Education Support
Visit Newsroom


No media attached. Please contact Scientific Education Support for more information.

Additional PR Formats

You just read:

Multiple Myeloma Hub | Quarter Four 2019 Update